oxazoles has been researched along with succinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, N; Bennett, JM; Berry, J; Collins, I; Czaplewski, LG; Haydon, DJ; Logan, A; Macdonald, R; Macleod, L; Mitchell, JP; Nayal, N; Peasley, H; Srivastava, A; Stokes, NR; Yadav, A | 1 |
| Fan, Y; Gao, C; Ge, Z; Gong, W; He, S; Huang, X; Shan, L; Tong, Y; Wang, Y; Yang, M | 1 |
2 other study(ies) available for oxazoles and succinic acid
| Article | Year |
|---|---|
An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Biological Availability; Colony Count, Microbial; Cytokinesis; Cytoskeletal Proteins; Drug Resistance, Multiple, Bacterial; Female; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mutation; Oxazoles; Prodrugs; Staphylococcal Infections; Staphylococcus epidermidis; Succinates; Succinic Acid; Thigh; Treatment Outcome | 2013 |
Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Topics: Animals; Animals, Inbred Strains; Antineoplastic Agents; Biological Availability; Cinnamates; Citric Acid; Dogs; Drug Compounding; Drugs, Investigational; Excipients; Fumarates; Hydrogen-Ion Concentration; Imidazoles; Male; Nitriles; Oxazoles; Povidone; Prostatic Neoplasms; Random Allocation; Solubility; Succinic Acid; Suspensions; Tablets; Thiohydantoins | 2014 |